Back

Inhibition of chronic inflammation by low-dose aspirin medication

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Coronary artery disease: from bench to bedside Inflammation and microcirculation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Miss Annemarie Mohring

University Hospital Duesseldorf, Duesseldorf (Germany)

71 More presentations in this session

Presentation thumbnail
Doctor G. Chi (Boston, US)
Abstract Slides
Presentation thumbnail
Professor P. Pignatelli Spinazzola (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor B. Mahmoodi (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor J. Adjedj (Saint Laurent du Var, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Coronary artery disease: from bench to bedside

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021
thumbnail
Congress Presentation
Aspirin overuse in primary prevention: nationwide temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in adults with and without diabetes
25 August 2023
thumbnail
Webinar
Inflammation in cardiovascular disease and classification of human atherosclerotic plaques according to underlying biology and clinical presentation
10 September 2024
thumbnail
Congress Presentation
Reduced gastric injury with a novel, liquid lipid-aspirin formulation: results from a pooled, patient level analysis of two randomized endoscopy studies In healthy volunteers
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources